StockTipsArenaBeta

BUY Eris Lifesciences Limited — Sandeep Jain, Tradeswift

BUYEris Lifesciences Limited
Eris Lifesciences share price target & all analyst calls

bySandeep Jain, TradeswiftHorizon: NA (inferred Swing (≤2wk))7 Sept 2026via Zee Business (Live)

Entry₹1,327.4Inferred
Target₹1,430
Total upside +7.73% (call closed)
Stop loss₹1,270-4.32% risk
At expiry₹1,291.121 Sept 2026, 3:30 pm
Expired-2.73%
Follow Sandeep Jain for new calls(16% target hit, 74 closed calls)Get alertsWatch ERIS for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Sept 2026
4 supporting2 neutral1 opposing
Supports the BUY call (4)

Eris Lifesciences: லாபத்தில் **73%** அதிரடி வளர்ச்சி - பங்கு முதலீட்டாளர்கள் கவனத்திற்கு!

NewsGoogle News·2 Sept · 3w ago

(opens in new tab)

Eris Lifesciences FY26 Revenue ₹3,129 Cr

NewsGoogle News·2 Sept · 3w ago

(opens in new tab)

Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets

NewsEt-Markets·28 Aug · 3w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·9 Jul · 2mo ago

Neutral / worth noting (2)

Eris Lifesciences Limited has entered into a term loan agreement with Axis Bank Limited for ₹45,00,00,000. The company stated this is a routine financial adjustment and will not impact the expected Ne

NSE · Agreements·9 Sept · 2w ago

(opens in new tab)

Eris Lifesciences schedules analyst meet with HBM Partners on August 27

NewsGoogle News·24 Aug · 4w ago

(opens in new tab)
Weighs against the BUY call (1)

Krishnakumar Vaidyanathan has resigned as Executive Director & Chief Operating Officer (COO) of Eris Lifesciences Ltd, effective September 30, 2026, to pursue external professional opportunities. The

BSE · Company Update·11 Sept · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Eris Lifesciences

All analyst calls on Eris Lifesciences

More from Sandeep Jain, Tradeswift

Every call and its outcome